Holen Sie sich die Stockscreener-App
1.09
5.22%
-0.06
Handel nachbörslich:
1.13
0.04
+3.67%
Schlusskurs vom Vortag:
$1.15
Offen:
$1.13
24-Stunden-Volumen:
145.90K
Relative Volume:
0.02
Marktkapitalisierung:
$6.35M
Einnahmen:
$4.75M
Nettoeinkommen (Verlust:
$-7.83M
KGV:
5.0069
EPS:
0.2177
Netto-Cashflow:
$-7.24M
1W Leistung:
-12.10%
1M Leistung:
-19.85%
6M Leistung:
+85.82%
1J Leistung:
+45.33%
1-Tages-Spanne:
$1.09
$1.14
1-Wochen-Bereich:
$1.09
$1.3097
52-Wochen-Spanne:
$0.46
$4.44
Novabay Pharmaceuticals Inc Stock (NBY) Company Profile
Firmenname
Novabay Pharmaceuticals Inc
Sektor
Branche
Telefon
510-899-8800
Adresse
2000 Powell Street, Suite 1150, Emeryville, CA
Vergleichen Sie NBY mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
NBY
Novabay Pharmaceuticals Inc
|
1.09 | 6.91M | 4.75M | -7.83M | -7.24M | 0.2177 |
|
VRTX
Vertex Pharmaceuticals Inc
|
426.00 | 109.11B | 11.39B | 3.64B | 3.50B | 13.99 |
|
REGN
Regeneron Pharmaceuticals Inc
|
642.25 | 68.50B | 14.25B | 4.58B | 3.88B | 41.77 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
434.07 | 60.25B | 3.21B | 43.57M | 221.36M | 0.2405 |
|
ARGX
Argen X Se Adr
|
826.28 | 50.39B | 3.06B | 1.28B | 447.35M | 19.67 |
|
INSM
Insmed Inc
|
186.23 | 40.44B | 447.02M | -1.18B | -868.57M | -6.1812 |
Novabay Pharmaceuticals Inc Stock (NBY) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2019-09-18 | Eingeleitet | Ladenburg Thalmann | Buy |
| 2018-07-06 | Bestätigt | H.C. Wainwright | Buy |
| 2017-11-15 | Bestätigt | Laidlaw | Buy |
| 2017-06-05 | Eingeleitet | ROTH Capital | Buy |
| 2017-03-27 | Eingeleitet | Laidlaw | Buy |
| 2017-02-06 | Eingeleitet | Rodman & Renshaw | Buy |
| 2016-03-07 | Herabstufung | Maxim Group | Buy → Hold |
| 2015-12-14 | Bestätigt | Maxim Group | Buy |
| 2015-04-30 | Fortgesetzt | Maxim Group | Buy |
| 2013-03-06 | Eingeleitet | Ascendiant Capital Markets | Strong Buy |
| 2008-01-03 | Eingeleitet | Dawson James | Speculative Buy |
Alle ansehen
Novabay Pharmaceuticals Inc Aktie (NBY) Neueste Nachrichten
Will NovaBay Pharmaceuticals Inc. (B9P0) stock announce a stock splitJuly 2025 Technicals & Safe Capital Growth Plans - newser.com
Will NovaBay Pharmaceuticals Inc. stock recover faster than industry2025 Analyst Calls & Free Real-Time Market Sentiment Alerts - newser.com
Why NovaBay Pharmaceuticals Inc. stock fits value portfoliosRate Cut & Safe Capital Growth Stock Tips - newser.com
How NovaBay Pharmaceuticals Inc. stock performs in interest rate cycles2025 Major Catalysts & Fast Exit and Entry Strategy Plans - newser.com
Will NovaBay Pharmaceuticals Inc. stock benefit from commodity pricesPortfolio Value Summary & Verified Swing Trading Watchlist - newser.com
NovaBay Pharmaceuticals Inc. stock trendline breakdown2025 Price Momentum & Fast Momentum Entry Tips - newser.com
Price momentum metrics for NovaBay Pharmaceuticals Inc. explained2025 Volatility Report & Intraday High Probability Alerts - newser.com
Will NovaBay Pharmaceuticals Inc. (B9P0) stock benefit from commodity supercycleQuarterly Profit Review & AI Based Buy and Sell Signals - newser.com
Why analysts recommend NovaBay Pharmaceuticals Inc. (B9P0) stockJuly 2025 Breakouts & Real-Time Volume Analysis - newser.com
How NovaBay Pharmaceuticals Inc. stock moves on employment dataIPO Watch & Free Growth Oriented Trading Recommendations - newser.com
Will breakout in NovaBay Pharmaceuticals Inc. lead to full recovery2025 Market Trends & Scalable Portfolio Growth Methods - newser.com
Will NovaBay Pharmaceuticals Inc. (B9P0) stock outperform Dow JonesLong Setup & Fast Entry and Exit Trade Plans - newser.com
Heatmap analysis for NovaBay Pharmaceuticals Inc. and competitorsDividend Hike & AI Forecast for Swing Trade Picks - newser.com
Why NovaBay Pharmaceuticals Inc. stock is trending among retail traders2025 Earnings Impact & Daily Market Momentum Tracking - newser.com
Is NovaBay Pharmaceuticals Inc. stock undervalued vs historical averagesWeekly Trade Review & Step-by-Step Trade Execution Guides - newser.com
What margin trends mean for NovaBay Pharmaceuticals Inc. stockWeekly Trend Summary & Target Return Focused Picks - newser.com
Is NovaBay Pharmaceuticals Inc. stock attractive for retirement portfoliosWeekly Trend Report & AI Enhanced Trading Alerts - newser.com
Is NovaBay Pharmaceuticals Inc. (B9P0) stock positioned for digital growth eraStop Loss & Technical Pattern Based Signals - newser.com
Is NovaBay Pharmaceuticals Inc. stock undervalued after correctionProduct Launch & Free Reliable Trade Execution Plans - newser.com
How analysts revise price targets for NovaBay Pharmaceuticals Inc. (B9P0) stock2025 EndofYear Setup & Free Fast Gain Swing Trade Alerts - newser.com
Statistical indicators supporting NovaBay Pharmaceuticals Inc.’s strengthQuarterly Trade Review & Safe Capital Investment Plans - newser.com
Is NovaBay Pharmaceuticals Inc. stock undervalued historicallyWeekly Volume Report & Weekly Market Pulse Updates - newser.com
What technical signals suggest for NovaBay Pharmaceuticals Inc. stockJuly 2025 Breakouts & High Yield Equity Trading Tips - newser.com
Is NovaBay Pharmaceuticals Inc. (B9P0) stock a top dividend aristocrat candidateMarket Movement Recap & Community Driven Trade Alerts - newser.com
Can NovaBay Pharmaceuticals Inc. stock withstand economic slowdownQuarterly Portfolio Summary & AI Enhanced Execution Alerts - newser.com
Published on: 2025-10-31 05:01:56 - newser.com
Published on: 2025-10-31 04:04:18 - newser.com
Published on: 2025-10-31 00:58:47 - newser.com
Can NovaBay Pharmaceuticals Inc. stock beat analyst consensus2025 Analyst Calls & AI Enhanced Trade Execution Alerts - newser.com
Finanzdaten der Novabay Pharmaceuticals Inc-Aktie (NBY)
Umsatz
Nettogewinn
Free Cashflow
ENV
0.64%
0.35%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):